The Man Behind Rising 'Sun': Tale Of A Crorepati Druggist Who Borrowed Rs 10,000 To Start Business, Has A Net Worth Of Rs 1,46,090 Crore
Sun Pharmaceutical: Dilip Shanghvi, the 67-year-old Gujarati business tycoon, is the second-richest billionaire in the pharmaceutical sector after Cyrus Poonawalla. According to Forbes, Shanghvi's net worth is approximately Rs 1,46,090 crore. He is listed as the 97th richest person in the world by the magazine.
Jul 20, 2023, 22:27 PM IST
Who is Dilip Shanghvi? This Person Started Company With Capital Investment Of Just Rs 10,000, Now Has Net Worth Of Rs 1,32,963 Crore
Dilip Shanghvi is the founder and managing director of Sun Pharmaceutical Industries Limited, India's most valuable listed pharma outfit.
Jun 21, 2023, 10:56 AM IST
Sun Pharma Q3 profit zooms nearly 4-fold to Rs 1,241.85 crore
The company had posted a net profit of Rs 321.57 crore for the corresponding period of the previous fiscal hit by one-time deferred tax adjustment.
Feb 13, 2019, 10:12 AM IST
Sun Pharma acquires Japan's Pola Pharma
The acquisition of 100 per cent shares of Pola Pharma Inc Japan by the company's wholly owned subsidiary has been concluded, Sun Pharma said in a BSE filing.
Jan 03, 2019, 17:30 PM IST
Sebi examining whistleblower complaint against Sun Pharma: Tyagi
A whistleblower had last month approached Sebi with a document alleging various irregularities by the company, its promoter Shanghvi and others.
Dec 13, 2018, 12:31 PM IST
Sun Pharma to acquire Japan's Pola Pharma for USD 1 mn
Pola Pharma's portfolio mainly comprises dermatology products. It has two manufacturing facilities in Saitama with capabilities to manufacture topical products and injectables.
Nov 27, 2018, 10:55 AM IST
Forbes terms Patanjali's Acharya Balkrishna as 19th richest Indian
Reliance Industries Ltd. chief Mukesh Ambani sustained India`s wealthiest position for the 10th straight year as his net worth swelled to $38 billion (nearly Rs. 2.5 trillion).
Oct 05, 2017, 15:58 PM IST
Stock slide wipes off investor wealth by Rs 1.38 lakh crore
Following weakness in stocks, the total market capitalisation of BSE-listed companies slumped by Rs 1,38,726.77 crore to Rs 1,29,77,705 crore.
Aug 29, 2017, 18:32 PM IST
Sun Pharma, Samsung BioLogics ink $55.5 mn pact
As per the pact, Sun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab.
Jul 04, 2017, 14:34 PM IST
Sun Pharma shares hit 52-week low, tank over 13%
Shares of Sun Pharma on Monday crashed by over 13 percent after the company reported a 14 percent decline in consolidated net profit for the fourth quarter ended March.
May 29, 2017, 13:06 PM IST
Investor wealth surges over Rs 50 lakh crore in 3 years
Investor wealth has surged by over Rs 50 lakh crore since the Modi government was voted to power three years ago, with the Sensex surging to its lifetime high of 31,074.07 on Friday.
May 26, 2017, 18:08 PM IST
USFDA issues 11 observations for Sun Pharma's Dadra facility
Drug major Sun Pharmaceutical Industries has received 11 observations from the US health regulator after inspection of its Dadra facility.
Apr 22, 2017, 18:54 PM IST
Sun Pharma shares down 3%; m-cap dips by Rs 5,004 crore
Shares of Sun Pharma fell by 3 percent today amid reports of USFDA inspection at one of the company's plant.
Apr 07, 2017, 19:45 PM IST
USFDA to lift import alert on Sun Pharma's Mohali plant
The US health regulator has proposed to lift the import alert on Sun Pharma's Mohali (Punjab) based manufacturing plant.
Mar 14, 2017, 15:02 PM IST
Sun Pharma subsidiary invests 14.6% stake in US company for $13 million
Pharamceutical major Sun Pharma's subsidiary has invested USD 13 million (about Rs 88 crore) in the US-based scPharmaceuticals Inc, announced the company on Friday.
Dec 23, 2016, 12:37 PM IST
Sun Pharma to acquire oncology product from Novartis for $175 million
Drug major Sun Pharmaceutical Industries on Thursday said it it will acquire a branded oncology product, Odomzo, from Novartis for an upfront payment of USD 175 million.
Dec 22, 2016, 11:21 AM IST
Sun Pharma acquires Ocular Technologies Sarl
Pharmaceutical major Sun Pharma has informed BSE that it has completed the acquisition of the US-based eye care specialist Ocular Technologies Sarl.
Dec 16, 2016, 12:05 PM IST
Sun Pharma to acquire 85% stake in Russia's Biosintez
The country's largest drug firm Sun Pharma on Wednesday said it has signed definitive agreements to acquire 85.1 percent stake in Russia-based JSC Biosintez for USD 24 million.
Nov 23, 2016, 12:59 PM IST
Sun Pharma buys back Rs 675 crore shares
Sun Pharma today said it has completed buyback of shares worth Rs 675 crore to return surplus funds to its shareholders.
Oct 21, 2016, 12:33 PM IST
Sun Pharma gets clearance for buyback from SEBI
Sun Pharma gets clearance for buyback from SEBI. Watch this special segment and get to know more here.
Sep 14, 2016, 16:05 PM IST
